Navigation

Migraine (chronic) - botulinum toxin type A [ID462]

Botulinum toxin type A for the prophylaxis of headaches associated with chronic migraine.

Status: History
Expected date of issue: June 2012
Referral date: July 2011
Process: STA
Topic area:
 

NICE project team

Executive Lead: Gill Leng
Technical Lead: Scott Goulden
Communications manager: Paul Cooney
Project manager: Rebecca Pye
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 10 October 2011
1st appraisal committee meeting: 24 January 2012
2nd appraisal committee meeting 22 March 2012
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Allergan (botulinum toxin type A)

Patient/carer groups

  • Migraine Action
  • Migraine Trust

Professional groups

  • Association of British Neurologists
  • British Association for the Study of Headache (BASH)
  • British Pain Society
  • Institute of Neurology
  • Migraine In Primary Care Advisors
  • Primary Care Neurology Society
  • Royal College of Anaesthetists
  • Royal College of Nursing
  • Royal College of Physicians
  • United Kingdom Clinical Pharmacy Association

Others

  • Department of Health
  • Welsh Government

General

  • British National Formulary
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Healthcare Improvement Scotland
  • Medicines and Healthcare products Regulatory Agency

Comparator manufacturers

  • None

Relevant research groups

  • National Hospital for Neurology and Neurosurgery

Evidence Review Group

  • Warwick Evidence
  • National Institute for Health Research Health Technology Assessment Programme

Associated guideline groups

  • National Clinical Guidelines Centre

Top


 

Key documents

This page was last updated: 26 July 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.